|Primary End Point||Secondary End Point|
|Independent Variable||HR (95% CI)||Z Score||p Value||Independent Variable||HR (95% CI)||Z Score||p Value|
|History of diabetes||1.36 (1.10–1.69)||2.85||0.004||History of dyslipidemia||1.35 (1.12–1.63)||3.20||0.001|
|Age⁎||1.12 (1.03–1.21)||2.61||0.009||History of diabetes||1.43 (1.14–1.80)||3.10||0.002|
|Therapy with atorvastatin||0.82 (0.69–0.96)||−2.47||0.01||C-reactive protein†||1.04 (1.01–1.06)||2.75||0.006|
|C-reactive protein†||1.03 (1.01–1.05)||2.46||0.01||History of PCI||1.51 (1.10–2.08)||2.53||0.01|
|History of PCI||1.44 (1.08–1.94)||2.45||0.01||Therapy with atorvastatin||0.81 (0.68–0.97)||−2.36||0.02|
Multivariable models were also adjusted for variables significantly associated with the outcome of interest in the univariate analysis, including history of hypertension, hypercholesterolemia, smoking, myocardial infarction, heart failure, peripheral vascular disease, renal disease, and CABG; type of acute coronary syndrome at admission; previous use of aspirin, beta-blockers, calcium-channel blockers, and ACE/ARB inhibitors; baseline levels of cholesterol and triglycerides; and quartiles of baseline LDL-C. In the multivariate analysis, these variables were not statistically significant (p < 0.05) predictors of the outcomes.
CI = confidence interval; HR = hazard ratio; other abbreviations as in Table 1.